Voloridge Investment Management
THC icon

Voloridge Investment Management’s Tenet Healthcare THC Stock Holding History

Voloridge Investment Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-127,444
Closed -$24M – 1081
2026
Q1 		$24M Sell
127,444
-237,043
-65% -$49.9M 0.1% 299
2025
Q4 		$72.4M Buy
364,487
+151,219
+71% +$30.6M 0.25% 98
2025
Q3 		$43.3M Buy
213,268
+74,459
+54% +$13.2M 0.15% 168
2025
Q2 		$24.4M Buy
+138,809
New +$20.9M 0.09% 279
2023
Q4 		– Sell
-262,336
Closed -$17.3M – 1469
2023
Q3 		$17.3M Buy
262,336
+118,098
+82% +$8.83M 0.09% 314
2023
Q2 		$11.7M Buy
144,238
+82,979
+135% +$5.91M 0.06% 424
2023
Q1 		$3.64M Sell
61,259
-476,426
-89% -$26.5M 0.02% 785
2022
Q4 		$26.2M Buy
537,685
+491,568
+1,066% +$22.7M 0.15% 203
2022
Q3 		$2.38M Buy
46,117
+34,357
+292% +$2.04M 0.01% 936
2022
Q2 		$618K Buy
+11,760
New +$818K ﹤0.01% 1279
2022
Q1 		– Sell
-15,362
Closed -$1.25M – 1697
2021
Q4 		$1.25M Sell
15,362
-100,403
-87% -$7.34M 0.01% 1213
2021
Q3 		$7.69M Buy
115,765
+6,444
+6% +$457K 0.05% 521
2021
Q2 		$7.32M Buy
109,321
+102,250
+1,446% +$6.34M 0.05% 508
2021
Q1 		$368K Sell
7,071
-190,104
-96% -$9.61M ﹤0.01% 1231
2020
Q4 		$7.87M Buy
+197,175
New +$6.36M 0.07% 345
2020
Q3 		– Sell
-13,897
Closed -$252K – 1503
2020
Q2 		$252K Buy
13,897
+3,093
+29% +$60.9K ﹤0.01% 1163
2020
Q1 		$156K Sell
10,804
-35,530
-77% -$1.02M ﹤0.01% 997
2019
Q4 		$1.76M Buy
+46,334
New +$1.39M 0.03% 516
2019
Q2 		– Sell
-55,875
Closed -$1.61M – 1063
2019
Q1 		$1.61M Sell
55,875
-62,695
-53% -$1.55M 0.05% 340
2018
Q4 		$2.03M Buy
+118,570
New +$2.87M 0.09% 196
2018
Q3 		– Sell
-220,278
Closed -$7.39M – 459
2018
Q2 		$7.39M Buy
+220,278
New +$6.85M 0.2% 118
2015
Q4 		– Sell
-126,944
Closed -$4.69M – 302
2015
Q3 		$4.69M Buy
+126,944
New +$6.56M 0.22% 114

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Voloridge Investment Management's THC Position: Q2 2026 in Review

Voloridge Investment Management sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 127,444 shares — an estimated $24M sold.

Voloridge Investment Management first reported a position in THC in Q3 2015 and held it in 22 quarters. The position peaked at $72.4M in Q4 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Voloridge Investment Management reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 127,444 Tenet Healthcare shares in Q2 2026, an estimated $24M.
  • Voloridge Investment Management first reported a position in Tenet Healthcare in Q3 2015 and held it in 22 quarters.
  • Voloridge Investment Management's Tenet Healthcare position peaked at $72.4M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.